Abstract
The possibility of reprogramming adult somatic cells into pluripotent stem cells (iPSCs) has generated a renewed interest into stem cell research and promises to overcome several key issues, including the ethical concerns of using human embryonic stem cells and the difficulty of obtaining large numbers of adult stem cells (Belmonte et al., Nat Rev Genet, 2009). This approach is also not free from challenges like the mechanism of the reprogramming process, which has yet to be elucidated, and the warranties for safety of generated pluripotent cells, especially in view of their possible therapeutic use. Very recently, several new reprogramming methods have surfaced, which seem to be more appropriate than genetic reprogramming. Particularly, chemically induced pluripotent cells (CiPSs), obtained with recombinant proteins or small synthetic molecules, may represent a valid approach, simpler and possibly safer than the other ones.
| Original language | English |
|---|---|
| Pages (from-to) | 1230-1237 |
| Number of pages | 8 |
| Journal | Cell Death and Differentiation |
| Volume | 17 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2010 |
Fingerprint
ASJC Scopus subject areas
- Cell Biology
- Molecular Biology
- Medicine(all)
Cite this
Cell reprogramming : Expectations and challenges for chemistry in stem cell biology and regenerative medicine. / Anastasia, L.; Pelissero, G.; Venerando, B.; Tettamanti, G.
In: Cell Death and Differentiation, Vol. 17, No. 8, 08.2010, p. 1230-1237.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cell reprogramming
T2 - Expectations and challenges for chemistry in stem cell biology and regenerative medicine
AU - Anastasia, L.
AU - Pelissero, G.
AU - Venerando, B.
AU - Tettamanti, G.
PY - 2010/8
Y1 - 2010/8
N2 - The possibility of reprogramming adult somatic cells into pluripotent stem cells (iPSCs) has generated a renewed interest into stem cell research and promises to overcome several key issues, including the ethical concerns of using human embryonic stem cells and the difficulty of obtaining large numbers of adult stem cells (Belmonte et al., Nat Rev Genet, 2009). This approach is also not free from challenges like the mechanism of the reprogramming process, which has yet to be elucidated, and the warranties for safety of generated pluripotent cells, especially in view of their possible therapeutic use. Very recently, several new reprogramming methods have surfaced, which seem to be more appropriate than genetic reprogramming. Particularly, chemically induced pluripotent cells (CiPSs), obtained with recombinant proteins or small synthetic molecules, may represent a valid approach, simpler and possibly safer than the other ones.
AB - The possibility of reprogramming adult somatic cells into pluripotent stem cells (iPSCs) has generated a renewed interest into stem cell research and promises to overcome several key issues, including the ethical concerns of using human embryonic stem cells and the difficulty of obtaining large numbers of adult stem cells (Belmonte et al., Nat Rev Genet, 2009). This approach is also not free from challenges like the mechanism of the reprogramming process, which has yet to be elucidated, and the warranties for safety of generated pluripotent cells, especially in view of their possible therapeutic use. Very recently, several new reprogramming methods have surfaced, which seem to be more appropriate than genetic reprogramming. Particularly, chemically induced pluripotent cells (CiPSs), obtained with recombinant proteins or small synthetic molecules, may represent a valid approach, simpler and possibly safer than the other ones.
UR - http://www.scopus.com/inward/record.url?scp=77954656717&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954656717&partnerID=8YFLogxK
U2 - 10.1038/cdd.2010.14
DO - 10.1038/cdd.2010.14
M3 - Article
VL - 17
SP - 1230
EP - 1237
JO - Cell Death and Differentiation
JF - Cell Death and Differentiation
SN - 1350-9047
IS - 8
ER -